Table 2.

Pearson's Correlations with Plasminogen Activator Inhibitor-1

Variable	r	p	n
Age	0.10	0.50	51
Body mass index	0.25	0.08	51
Pericardial fata	0.72	<0.001	51
C-reactive proteinc	0.00	0.98	50
Duration of diabetesc	0.10	0.49	51
Hemoglobin A1cc	0.03	0.86	50
HOMA-IR [(glucose × insulin/405)]b,c	0.31	0.03	51
Systolic blood pressure	0.22	0.12	51
Diastolic blood pressurec	0.05	0.74	51
Triglyceridesb,c	0.27	0.05	51
Cholesterolc	0.09	0.55	51
High-density lipoproteinc	0.16	0.25	51
24-hr urine creatinine	0.17	0.22	51
24-hr urine sodium	0.07	0.62	51
24-hr urine aldosteronec	0.25	0.07	51
Aldosterone, baselinec	0.10	0.49	51
Angiotensin II-stimulated aldosteronec	0.01	0.95	44
Myocardial ECV	0.02	0.91	51
CFRc	0.25	0.08	50
ASCVD 10-year riskc	0.16	0.26	51
ASCVD lifetime riskc	0.24	0.09	51

^aP ≤ 0.01.

^bP ≤ 0.05.

^cRepresents a variable log-transformed for Pearson's correlation.

ASCVD, atherosclerotic cardiovascular disease; CFR, cornoary flow reserve; HOMA-IR, homeostatic model assessment of insulin resistance.